Stock listing
Prime Medicine, Inc.
Selected listing: PRME · NASDAQ · USD · US
Prime Medicine, Inc. (NASDAQ:PRME), Health Technology. Latest release Oct 5, 2026: Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical…
- Ticker
- NASDAQ:PRME
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Prime Medicine, Inc.
Prime Medicine, Inc. is a public company traded under the ticker PRME in the American market.
Latest news from Prime Medicine, Inc.
Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease
October 5, 2026
Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM647 in Alpha-1 Antitrypsin Deficiency
September 24, 2026
Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 6, 2026
Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease
July 23, 2026
Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics
July 8, 2026
Research Prime Medicine, Inc.
Prime Medicine, Inc. company profile
View the public company page for Prime Medicine, Inc. on 6ix.
Prime Medicine, Inc. news
Read company news and market updates connected to Prime Medicine, Inc..
Prime Medicine, Inc. investor events
Find investor webinars, events, and replay context for Prime Medicine, Inc..